| Year |
Citation |
Score |
| 2014 |
Salinas CA, Tsodikov A, Ishak-Howard M, Cooney KA. Prostate cancer in young men: an important clinical entity. Nature Reviews. Urology. 11: 317-23. PMID 24818853 DOI: 10.1038/Nrurol.2014.91 |
0.704 |
|
| 2012 |
Zuhlke KA, Johnson AM, Okoth LA, Stoffel EM, Robbins CM, Tembe WA, Salinas CA, Zheng SL, Xu J, Carpten JD, Lange EM, Isaacs WB, Cooney KA. Identification of a novel NBN truncating mutation in a family with hereditary prostate cancer. Familial Cancer. 11: 595-600. PMID 22864661 DOI: 10.1007/S10689-012-9555-1 |
0.652 |
|
| 2012 |
Lange EM, Salinas CA, Zuhlke KA, Ray AM, Wang Y, Lu Y, Ho LA, Luo J, Cooney KA. Early onset prostate cancer has a significant genetic component. The Prostate. 72: 147-56. PMID 21538423 DOI: 10.1002/Pros.21414 |
0.675 |
|
| 2011 |
Kwon EM, Salinas CA, Kolb S, Fu R, Feng Z, Stanford JL, Ostrander EA. Genetic polymorphisms in inflammation pathway genes and prostate cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 923-33. PMID 21430300 DOI: 10.1158/1055-9965.Epi-10-0994 |
0.728 |
|
| 2010 |
Salinas CA, Kwon EM, FitzGerald LM, Feng Z, Nelson PS, Ostrander EA, Peters U, Stanford JL. Use of aspirin and other nonsteroidal antiinflammatory medications in relation to prostate cancer risk. American Journal of Epidemiology. 172: 578-90. PMID 20688905 DOI: 10.1093/Aje/Kwq175 |
0.776 |
|
| 2010 |
Agalliu I, Kwon EM, Salinas CA, Koopmeiners JS, Ostrander EA, Stanford JL. Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based study. Cancer Causes & Control : Ccc. 21: 289-300. PMID 19902366 DOI: 10.1007/S10552-009-9461-5 |
0.633 |
|
| 2010 |
Cooney KA, Salinas CA, Ray AM, Wang Y, Lange EM, Zuhlke KA. Evaluation of the genetic component of early-onset prostate cancer. Journal of Clinical Oncology. 28: 4502-4502. DOI: 10.1200/Jco.2010.28.15_Suppl.4502 |
0.455 |
|
| 2009 |
Wright JL, Salinas CA, Lin DW, Kolb S, Koopmeiners J, Feng Z, Stanford JL. Prostate cancer specific mortality and Gleason 7 disease differences in prostate cancer outcomes between cases with Gleason 4 + 3 and Gleason 3 + 4 tumors in a population based cohort. The Journal of Urology. 182: 2702-7. PMID 19836772 DOI: 10.1016/J.Juro.2009.08.026 |
0.733 |
|
| 2009 |
Fitzgerald LM, Kwon EM, Koopmeiners JS, Salinas CA, Stanford JL, Ostrander EA. Analysis of recently identified prostate cancer susceptibility loci in a population-based study: associations with family history and clinical features. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 3231-7. PMID 19366831 DOI: 10.1158/1078-0432.Ccr-08-2190 |
0.74 |
|
| 2009 |
Penney KL, Salinas CA, Pomerantz M, Schumacher FR, Beckwith CA, Lee GS, Oh WK, Sartor O, Ostrander EA, Kurth T, Ma J, Mucci L, Stanford JL, Kantoff PW, Hunter DJ, et al. Evaluation of 8q24 and 17q risk loci and prostate cancer mortality. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 3223-30. PMID 19366828 DOI: 10.1158/1078-0432.Ccr-08-2733 |
0.714 |
|
| 2009 |
Salinas CA, Koopmeiners JS, Kwon EM, FitzGerald L, Lin DW, Ostrander EA, Feng Z, Stanford JL. Clinical utility of five genetic variants for predicting prostate cancer risk and mortality. The Prostate. 69: 363-72. PMID 19058137 DOI: 10.1002/Pros.20887 |
0.769 |
|
| 2008 |
Holt SK, Salinas CA, Stanford JL. Vasectomy and the risk of prostate cancer. The Journal of Urology. 180: 2565-7; discussion 2. PMID 18930503 DOI: 10.1016/J.Juro.2008.08.042 |
0.773 |
|
| 2008 |
Kote-Jarai Z, Easton DF, Stanford JL, Ostrander EA, Schleutker J, Ingles SA, Schaid D, Thibodeau S, Dörk T, Neal D, Donovan J, Hamdy F, Cox A, Maier C, Vogel W, ... ... Salinas CA, et al. Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 2052-61. PMID 18708398 DOI: 10.1158/1055-9965.Epi-08-0317 |
0.747 |
|
| 2008 |
Agalliu I, Salinas CA, Hansten PD, Ostrander EA, Stanford JL. Statin use and risk of prostate cancer: results from a population-based epidemiologic study. American Journal of Epidemiology. 168: 250-60. PMID 18556686 DOI: 10.1093/Aje/Kwn141 |
0.696 |
|
| 2008 |
Salinas CA, Kwon E, Carlson CS, Koopmeiners JS, Feng Z, Karyadi DM, Ostrander EA, Stanford JL. Multiple independent genetic variants in the 8q24 region are associated with prostate cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 1203-13. PMID 18483343 DOI: 10.1158/1055-9965.Epi-07-2811 |
0.706 |
|
| 2006 |
Agalliu I, Lin DW, Salinas CA, Feng Z, Stanford JL. Polymorphisms in the glutathione S-transferase M1, T1, and P1 genes and prostate cancer prognosis. The Prostate. 66: 1535-41. PMID 16921513 DOI: 10.1002/Pros.20491 |
0.734 |
|
| 2006 |
Salinas CA, Agalliu I, Stanford JL, Lin DW. Statins and the risk of cancer. Jama. 295: 2721; author reply 2. PMID 16788124 DOI: 10.1001/Jama.295.23.2721-A |
0.641 |
|
| 2006 |
Agalliu I, Langeberg WJ, Lampe JW, Salinas CA, Stanford JL. Glutathione S-transferase M1, T1, and P1 polymorphisms and prostate cancer risk in middle-aged men. The Prostate. 66: 146-56. PMID 16173036 DOI: 10.1002/Pros.20305 |
0.716 |
|
| 2005 |
Salinas CA, Austin MA, Ostrander EO, Stanford JL. Polymorphisms in the androgen receptor and the prostate-specific antigen genes and prostate cancer risk. The Prostate. 65: 58-65. PMID 15810021 DOI: 10.1002/Pros.20230 |
0.758 |
|
| 2005 |
Schoonen WM, Salinas CA, Kiemeney LA, Stanford JL. Alcohol consumption and risk of prostate cancer in middle-aged men. International Journal of Cancer. 113: 133-40. PMID 15386436 DOI: 10.1002/ijc.20528 |
0.709 |
|
| Show low-probability matches. |